BridgeBio price target raised to $49 from $48 at Scotiabank
Scotiabank analyst Greg Harrison raised the firm’s price target on BridgeBio (BBIO) to $49 from $48 and keeps an Outperform rating on the shares. BridgeBio recently announced its European partner ...
Monday.com price target raised to $400 from $300 at Scotiabank
Scotiabank analyst Allan Verkhovski raised the firm’s price target on Monday.com (MNDY) to $400 from $300 and keeps an ...